Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy
Clinical trial NCT02607800 · COMPLETED
Trial details
- NCT number
- NCT02607800
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-16
- Primary completion
- 2016-10-10
- Enrollment
- 943
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.